10/14/21 1:30 AMOTC : ADOCYclinical trialAdocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in ChinaAdocia, a clinical stage biopharmaceutical company focused on diabetes treatments and other metabolic diseases with innovative formulations of proteins and peptides, announced today that its partner Tonghua Dongbao Pharmaceutical Co. Ltd. received clearance from the Center for Drug Evaluation of the China National Medical Products Administration...RHEA-AIvery positive
10/12/21 12:00 PMOTC : ADOCYNumber of Shares and Voting Rights of ADOCIA as of September 30th, 2021Pursuant to the provisions of article L. 233-8 II of the French« Code de Commerce » and article 223-16 of the French stock-market authorities charter ADOCIA SA, a French société anonyme, 115, avenue Lacassagne, 69003 Lyon, a clinical stage biopharmaceutical company focused on treatment of diabetes, obesity and metabolic diseases with innovative...RHEA-AIneutral
09/21/21 12:00 PMOTC : ADOCYAdocia Announces Oral Presentation Reviewing M1Pram (ADO09) at the 57th Annual Meeting of the European Association for the Study of Diabetes (EASD)Adocia, a clinical-stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announced today that it will deliver an oral presentation covering proprietary M1Pram pramlintide insulin at the 57th Annual Meeting of the European Association for the Study of...RHEA-AIneutral
09/13/21 12:00 PMOTC : ADOCYNumber of Shares and Voting Rights of ADOCIA as of August 31st, 2021Pursuant to the provisions of article L. 233-8 II of the French« Code de Commerce » and article 223-16 of the French stock-market authorities charter ADOCIA SA, a French société anonyme, 115, avenue Lacassagne, 69003 Lyon, a clinical stage biopharmaceutical company focused on treatment of diabetes, obesity and metabolic diseases with innovative...RHEA-AIneutral
09/10/21 1:30 AMOTC : ADOCYconferencesAdocia to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceAdocia, a clinical-stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announced today that Gerard Soula, Adocia’ s CEO, will be presenting at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place from September 13 to 15, 2021.RHEA-AIneutral
09/07/21 12:00 PMOTC : ADOCYearningsAdocia Announces First Half 2021 Financial Results and Provides an Update on ActivitiesAdocia, the clinical-stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announces today its financial results for the six months ended June 30 th, 2021.. "Our strategy is based on the late-stage development of our ultra-rapid insulin in China and the...RHEA-AIneutral
